CXCR3 and its ligands CXCL9 and CXCL10, as well as CCR5 and its ligand CCL5, recruit both Treg cells (pro-tumor immune cell) and CTLs (anti-tumor immune cell) 183. This evidence concerns the gene CCR5 and neoplasm.